Topic

Washington

A collection of 516 issues

Renewing Kuvan (Sapropterin) Approval with UnitedHealthcare in Washington: 2025 Requirements & Timeline

Answer Box: Kuvan Renewal Requirements UnitedHealthcare requires annual prior authorization renewal for Kuvan (sapropterin) with specific documentation: active phenylalanine-restricted diet, sustained blood Phe reduction from baseline (typically ≥20-30%), and confirmation you're not using concurrent Palynziq therapy. Start renewal 60-90 days before expiration. Submit through the UnitedHealthcare Provider Portal

How to Get Waylivra (Volanesorsen) Covered by UnitedHealthcare in Washington: Appeals, Forms & State Protections

Answer Box: Getting Waylivra Covered by UnitedHealthcare in Washington Waylivra (volanesorsen) is typically non-formulary on UnitedHealthcare plans, requiring an individualized coverage exception. In Washington, you have strong appeal rights including independent external review after internal denials. Fastest path: Submit a detailed prior authorization request with genetic FCS confirmation, documented treatment

Renewing Haegarda (C1-Esterase Inhibitor) Approval with Blue Cross Blue Shield in Washington: Timeline, Forms & Appeal Process

Answer Box: Renewing Haegarda with Blue Cross Blue Shield in Washington Blue Cross Blue Shield plans in Washington require annual renewal for Haegarda (C1-esterase inhibitor) with documentation of continued HAE diagnosis and clinical benefit. Start your renewal 60-90 days before expiration by submitting updated attack logs, specialist notes showing reduced

If Tavneos (Avacopan) Isn't Approved by Cigna in Washington: Formulary Alternatives and Exception Strategies

Answer Box: Quick Start Guide If Cigna denies Tavneos (avacopan) for ANCA-associated vasculitis in Washington, you have three main paths forward: 1) Try formulary alternatives like rituximab or cyclophosphamide that may have easier approval, 2) Request a formulary exception with strong clinical evidence showing why alternatives are inadequate, or 3)

A Realistic Jynarque (Tolvaptan) Approval Scenario with Cigna in Washington (From Request to Yes)

Quick Answer: Getting Jynarque (Tolvaptan) Covered by Cigna in Washington Path to approval: Submit Cigna prior authorization with documented rapid ADPKD progression (Mayo class 1C-1E or eGFR decline ≥3 mL/min/1.73m²/year), baseline labs, and REMS enrollment. If denied, file internal appeal within 180 days, then external review

How to Get Kineret (anakinra) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization Guide

Answer Box: Getting Kineret Covered by Blue Cross Blue Shield in Washington Blue Cross Blue Shield plans in Washington (Premera Blue Cross and Regence BlueShield) require prior authorization for Kineret (anakinra). Success depends on documenting failed conventional DMARDs for rheumatoid arthritis or confirmed NOMID diagnosis. If denied, Washington's

How to Get Onpattro (patisiran) Covered by Aetna CVS Health in Washington: Complete Prior Authorization and Appeal Guide

Answer Box: Your Fastest Path to Onpattro Coverage To get Onpattro (patisiran) covered by Aetna CVS Health in Washington: Submit the Onpattro precertification form with genetic testing confirming hATTR-PN, baseline mNIS+7 scores, and neurologist evaluation. Aetna typically decides within 5-10 business days. If denied, file internal appeal within 180

How to Get Sumavel DosePro Covered by Humana in Washington: Complete Appeal Guide with Templates

Quick Answer: Humana typically requires step therapy through oral triptans before covering Sumavel DosePro (sumatriptan injection). In Washington, you have 65 days to file a Medicare Advantage appeal or 60 days for commercial plans. Start by having your doctor document failed oral triptan trials and submit a detailed prior authorization

How to Get Imbruvica (ibrutinib) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization & Appeal Guide

Answer Box: Getting Imbruvica Covered by Blue Cross Blue Shield in Washington Blue Cross Blue Shield plans in Washington (Premera, Regence) require prior authorization for Imbruvica (ibrutinib) with specific renewal criteria including no disease progression and continued monitoring commitment. Your fastest path to approval: have your oncologist submit urgent PA

Myths vs. Facts: Getting Xyrem (Sodium Oxybate) Covered by Blue Cross Blue Shield in Washington

Answer Box: Getting Xyrem Covered by Blue Cross Blue Shield in Washington Blue Cross Blue Shield plans in Washington (Premera, Regence/UMP) almost always require prior authorization for Xyrem (sodium oxybate) for narcolepsy. Success depends on complete REMS enrollment, documented narcolepsy diagnosis with sleep studies, and proof of failed stimulant